Today: 9 April 2026
Subscribe
Browse Category

NYSE:TMO 23 January 2026 - 15 February 2026

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher shares rose 0.1% to $543.48 Monday after the company filed for a four-part senior notes offering to help fund its planned Clario acquisition. The preliminary prospectus left key terms blank and showed $39.38 billion in consolidated debt as of Dec. 31, 2025. S&P rated the proposed debt ‘A-’. Executive Gianluca Pettiti filed to sell 400 shares valued at $216,480.
9 February 2026
·
Thermo Fisher stock price: TMO ends week near $543 — what matters before Monday’s open

Thermo Fisher stock price: TMO ends week near $543 — what matters before Monday’s open

Thermo Fisher shares closed Friday at $542.83, up 0.09% for the day but down 6.7% since Feb. 2 after a steep midweek drop. The company’s 2026 forecast cited pressure from U.S. academic research funding cuts and projected adjusted profit of $24.22 to $24.80 a share. The planned $8.9 billion Clario acquisition is expected to close by mid-2026. Broader sector peers outperformed Thermo Fisher into the weekend.
8 February 2026
·
Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher shares rose 0.6% to $545.58 Friday afternoon, recovering some ground after a 4% drop Thursday. The move lagged the broader market, with the S&P 500 up 1.73%. Investors remain cautious amid weak academic research funding and uncertain lab order trends. Upcoming U.S. jobs and inflation data could affect rate expectations and valuations.
6 February 2026
··
Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific shares fell 2.29% to $578.61 Friday, extending a four-day slide after issuing a cautious 2026 outlook and forecasting earnings below Wall Street’s average estimate. Volume reached 3.7 million shares, nearly double the daily average. The company cited continued pressure from frozen academic research grants. Fourth-quarter revenue rose 7% to $12.21 billion, with adjusted EPS at $6.57.
31 January 2026
·
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
·····
Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher shares fell 2.6% to $592.16 after the company forecast 2026 profits below Wall Street estimates, citing weaker U.S. academic research funding. The company projected adjusted earnings of $24.22 to $24.80 per share, missing consensus. Fourth-quarter revenue rose 7% to $12.21 billion, beating expectations. CFO Stephen Williamson will retire in March, with Jim Meyer named as successor.
30 January 2026
··
Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher shares fell 2.6% to $592.08 after the company forecast 2026 adjusted profit below Wall Street estimates, citing continued weakness in U.S. academic and government funding. The firm projected 2026 adjusted EPS of $24.22–$24.80 and revenue of $46.3–$47.2 billion. Fourth-quarter revenue rose 7% to $12.21 billion. Investors are watching the timing of the Clario acquisition, expected to close by mid-2026.
29 January 2026
··
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher shares fell 2.55% to $608.02 Wednesday, their second straight decline ahead of Thursday’s Q4 earnings call. Trading volume topped 2.3 million, above average, as investors weighed Danaher’s warning on weak academic research funding. The stock now sits 5.6% below its Jan. 22 high. Life-science tools stocks broadly declined during the session.
29 January 2026
···
Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher shares rose 0.8% to $631.24 by midday Monday in New York, rebounding from an early dip ahead of Thursday’s earnings report and 2026 outlook. Options markets point to an expected 4% swing after results. Analysts forecast Q4 earnings of $6.43 per share, up from $6.10 a year ago. The company will hold its earnings call at 8:30 a.m. ET on Jan. 29.
26 January 2026
··
Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher shares fell 2.11% to $625.98 Friday, ending a three-day rally and closing 2.8% below Thursday’s 52-week high. The company reports earnings before the market opens Jan. 29, following Danaher’s results and the Fed’s Jan. 27-28 meeting. The S&P 500 health care index slipped 0.56% Friday. Analyst consensus expects Thermo Fisher to post $6.44 EPS on $11.95 billion revenue for the quarter.
25 January 2026
···
Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher Scientific shares fell 2.1% to $625.98 on Friday, reversing after a 52-week high the previous day. Trading volume was above average as investors positioned ahead of next week’s earnings and a Federal Reserve meeting. The company’s 1.400% senior notes due 2026 are being delisted from the NYSE. Thermo Fisher reports fourth-quarter results before markets open on Jan. 29.
24 January 2026
··
Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher Scientific shares fell 2.1% to $625.98 Friday, ending a three-day rally and retreating from a 52-week high. The drop came ahead of the company’s Jan. 29 earnings release and as peers Waters and Danaher also declined about 2%, signaling profit-taking in the life-sciences tools sector. Investors await updates on Thermo Fisher’s planned Clario acquisition and outlook for 2026.
24 January 2026
··
Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher Scientific shares fell nearly 2% by midday Friday, reversing earlier gains after touching a record high near $640. The drop outpaced the broader market, with peers Danaher, Agilent, and Illumina also declining. Investors are awaiting Thermo Fisher’s fourth-quarter results, set for release before the market opens on Jan. 29. The S&P 500 was steady while the health-care sector slipped.
23 January 2026
··
Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher Scientific shares fell 1.2% to $631.70 in late morning trading Friday, ending a two-day rally as investors awaited the company’s Jan. 29 earnings report. Peers Danaher and Agilent also declined. Traders are watching for management’s outlook on demand and margins. A recent minor debt security filing drew some attention but did not involve common stock.
23 January 2026
··
Thermo Fisher stock price holds near a fresh 52-week high with earnings next week in focus

Thermo Fisher stock price holds near a fresh 52-week high with earnings next week in focus

Thermo Fisher shares closed up 0.5% at $639.43 Thursday after hitting a new 52-week high, with little change in after-hours trading. The company will report fourth-quarter and full-year results before the market opens Jan. 29. Investors are watching for signals on lab and biopharma spending. Peers Danaher and Agilent slipped, while Waters rose late Thursday.
23 January 2026
··
1 2 3 4

Stock Market Today

  • Insider Buying Highlights Kayne Anderson MLP and Navios Maritime Partners
    April 9, 2026, 10:55 AM EDT. Insider buying activity drew attention Thursday with Kayne Anderson MLP Investment Company (KYN) President James C. Baker purchasing 25,000 shares at $13.67 each, investing $341,750. Baker's average purchase price over the past year is $12.72, and shares have risen about 3.9% post-purchase, with KYN up 2.3% for the day. Meanwhile, Angeliki Frangou acquired 3,581 shares of Navios Maritime Partners LP (NMM) at $70.66 each, totaling $253,025. Frangou's average cost over four prior buys stands at $66.91; following this latest buy, NMM edged up 0.2%, peaking 2.7% above her purchase price. Both insiders appear confident, backing their companies with substantial recent investments amid moderate stock gains.

Latest article

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Grab Holdings Bets on AI as Group Ride Tool Targets 40% Lower Fares

Grab Holdings Bets on AI as Group Ride Tool Targets 40% Lower Fares

9 April 2026
Grab Holdings launched 13 new AI-powered products in Jakarta, including a “Group Ride” feature that can cut fares by up to 40% for shared routes. CEO Anthony Tan said the tools aim to offset rising fuel costs and support demand as households tighten spending. The company’s 2026 revenue and profit forecasts remain below analyst expectations. Grab’s $600 million deal to buy Foodpanda Taiwan is pending regulatory approval.
Nokia Oyj AI Data Center Push Gets Lift From Fifth Straight GigaOm Leader Ranking

Nokia Oyj AI Data Center Push Gets Lift From Fifth Straight GigaOm Leader Ranking

9 April 2026
Nokia was named a Leader and Outperformer in GigaOm’s 2026 Radar for data center switching for the fifth year in a row, competing with Cisco, Arista, and HPE Juniper. Shares fell 1.05% in Helsinki ahead of Thursday’s annual meeting, where board changes and a dividend of up to 14 euro cents per share will be considered.
American Airlines Faces FAA Fine Over Drug-Testing Lapses in New Test for 2026 Turnaround

American Airlines Faces FAA Fine Over Drug-Testing Lapses in New Test for 2026 Turnaround

9 April 2026
The FAA proposed a $255,000 civil penalty against American Airlines, alleging the carrier allowed 12 flight attendants who tested positive for drugs or alcohol to return to safety-sensitive duties before completing required follow-up tests. The alleged violations occurred from May 2019 to December 2023. American has 30 days to respond. The airline said it is reviewing the notice.
Go toTop